Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 USD | -2.72% | +5.92% | +78.16% |
May. 07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
May. 01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.61B 3.27B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 105 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 11.86% |
Latest transcript on Summit Therapeutics Inc.
1 day | -2.72% | ||
1 week | +5.92% | ||
Current month | +18.32% | ||
1 month | +15.38% | ||
3 months | +3.33% | ||
6 months | +144.09% | ||
Current year | +78.16% |
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Robert Booth
BRD | Director/Board Member | 70 | 22-09-27 |
Director of Finance/CFO | 46 | 19-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 4.65 | -2.72% | 1,781,959 |
24-05-09 | 4.78 | -3.63% | 2,083,819 |
24-05-08 | 4.96 | -6.59% | 2,724,963 |
24-05-07 | 5.31 | +18.79% | 4,802,569 |
24-05-06 | 4.47 | +1.82% | 1,326,982 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+78.16% | 3.26B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SMMT Stock